Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven cancers, today announced ...
IN RECENT times, concern for the country has grown significantly. The ongoing geopolitical tensions involving countries such ...
Seoul National University College of Engineering announced that a research team led by Prof. Sung-Hoon Ahn of the Department ...
The FDA today announced a new initiative to allow its reviewers to access information from clinical trials in real time, with ...
For once, the Federal Executive Council sat down, looked at a 20-year mess, and decided to end it. No drama, no fresh committee, no white paper gathering dust ...
Argo Biopharma begins patient dosing in phase II trials of siRNA therapy BW-40202: Shanghai, China Wednesday, April 22, 2026, 15:00 Hrs [IST] Argo Biopharmaceutical Co., Ltd. (Arg ...
Argo Biopharmaceutical Co., Ltd. (Argo Biopharma), a clinical-stage small interfering RNA (siRNA) therapeutics company, today announced the first patient has been dosed in multiple Phase II studies of ...
Penguin-inspired film switches between heating, cooling and microwave shielding, pointing to adaptive surfaces for buildings, ...
Hemisphere GNSS, a CNH brand, and Calian Group Ltd have introduced the A65 GNSS antenna, a jointly built next-generation ...
Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotechnology company pioneering RNA interference ...
Iran’s envoy to India explains Tehran’s stance on war and peace in West Asia, India’s balanced role between Iran, the US and ...